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Summary
Background.— Higher resting heart rate, a simple and useful indicator of autonomic balance
and metabolic rate, has emerged as an independent predictor for atherosclerotic cardiovascular
disease.
Aim.— To determine the association between resting heart rate and arterial stiffness measured
by brachial-ankle pulse wave velocity (baPWV).
Methods.— We examined the association between resting heart rate and baPWV in 641 Korean
adults (366 men, 275 women) in a health examination program. A high baPWV was deﬁned as
greater than 1450 cm/s (> 75th percentile). The odds ratios for high baPWVs were calculated
using multivariable logistic regression analysis after adjusting for confounding variables across
heart rate quartiles (Q1≤ 56, Q2 = 57—62, Q3 = 63—68, Q4≥ 69 beats/min).
Results.— Age-adjusted baPWV mean values increased gradually with heart rate quartile
(Q1 = 1281, Q2 = 1285, Q3 = 1354, Q4 = 1416 cm/s). The odds ratios (95% conﬁdence intervals) for
high baPWVs in each heart rate quartile were 1.00, 1.28 (0.57—2.86), 2.63 (1.20—5.79) and 3.66
(1.66—8.05), respectively, after adjusting for age, sex, smoking status, alcohol intake, exercise,
body mass index, hypertension medication, diabetes medication, hyperlipidaemia medication,
mean arterial blood pressure, fasting plasma glucose, total cholesterol, triglycerides, high-
density lipoprotein cholesterol, white blood cell count, aspartate aminotransferase, alanine
aminotransferase, -glutamyltransferase and uric acid.
Abbreviations: baPWV, brachial-ankle pulse wave velocity; CI, conﬁdence interval; HDL, high-density lipoprotein; HR, heart rate; PWV,
pulse wave velocity; WBC, white blood cell.
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Heart rate and arterial stiffness
MOTS CLÉS
Rythme cardiaque ;
Maladie
cardiovasculaire ;
Rigidité artérielle ;
Vitesse de l’onde de
pouls
indépendamment associé avec la rigidité artérielle. En conséquence, un dépistage rapide d’un
rythme cardiaque plus élevé au repos est important pour la préservation de la fonction artérielle
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Background
Resting heart rate (HR) is a simple and useful indicator of
autonomic balance and metabolic rate [1]. Emerging evi-
dence has shown that higher resting HR is linked closely
to all-cause and cardiovascular disease mortality [2—4],
but the mechanism remains unclear. Higher HR may be
associated with oxidative stress and chronic subclinical
inﬂammation because of the increased rate of oxygen con-
sumption [5—7]. Chronic low-grade arterial inﬂammation is
known to be associated with the pathogenesis of cardio-
vascular disease [8,9]. Several studies have reported that
various inﬂammatory markers, such as high-sensitivity C-
reactive protein, erythrocyte sedimentation rate, and white
blood cell (WBC) count, are associated with arterial stiffness
[10,11].
Increased arterial stiffness as measured by pulse wave
velocity (PWV) has been reported to be a signiﬁcant
predictor of cardiovascular events and mortality [12,13].
Recently, a simple, automated device has become available
for the measurement of brachial-ankle pulse wave veloc-
ity (baPWV), using a volume-rendering method. Measuring
baPWV is easier and more efﬁcient than conventional mea-
surements of aortic PWV and also has a good correlation
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s droits réservés.
ith aortic PWV [14]. Moreover, a previous study assessed
nd conﬁrmed the validity, reliability and reproducibility of
his measurement [15].
If the link between resting HR and cardiovascular dis-
ase morbidity and mortality is indeed mediated by chronic
ow-grade arterial inﬂammation, we would expect posi-
ive associations between resting HR and arterial stiffness.
herefore, we examined the associations of resting HR with
rterial stiffness in Korean adults, as measured by baPWV.
ethods
tudy population
e reviewed the medical records of 728 participants (416
en, 312 women) who underwent a medical examination at
he health promotion centre in Gangnam Severance Hospi-
al, Yonsei University College of Medicine between March247
Conclusion.— These ﬁndings indicate that a higher resting heart rate is independently asso-
ciated with arterial stiffness. Accordingly, early detection of increased resting heart rate is
important for preservation of arterial function and assessment of cardiovascular risk.
© 2010 Elsevier Masson SAS. All rights reserved.
Résumé
Le contexte.— Un rythme cardiaque plus élevé au repos, un indicateur simple et utile de
l’équilibre autonome et du métabolisme, est apparu comme un indicateur de maladie car-
diovasculaire athérosclérotique.
Objectif.— Déterminer l’association du rythme cardiaque élevé au repos avec la rigidité
artérielle par la vitesse de l’onde de pouls cheville/bras (brachial-ankle pulse wave velocity
[baPWV]).
Méthode.— Nous examinons l’association entre le rythme cardiaque élevé au repos et le baPWV
sur 641 adultes coréens (366 hommes, 275 femmes) dans le cadre du programme de l’examen.
Un baPWV élevé est déﬁni lorsque que celui-ci dépasse plus de 1450 cm/s (> 75e percentile).
L’odds ratio (ou rapport de chances) pour le baPWV élevé a été calculé en utilisant l’analyse
de la régression logistique multivariée, après rectiﬁcation des variables de perturbation à
travers les quartiles du rythme cardiaque élevé au repos (Q1≤ 56, Q2 = 57—62, Q3 = 63—68 et
Q4≥ 69 battements par minute).
Résultats.— Le baPWV à l’âge ajusté signiﬁe que les valeurs ont progressivement augmenté
avec le quartile du rythme cardiaque élevé au repos (Q1 = 1281, Q2 = 1285, Q3 = 1354 et
Q4 = 1416 cm/s). L’odds ratio (95 % CI) pour le baPWV élevé dans chaque quartile du rythme
cardiaque élevé au repos était 1,00 ; 1,28 (0,57—2,86) ; 2,63 (1,20—5,79) et 3,66 (1,66—8,05),
après l’ajustement de l’âge, du sexe, du tabagisme, de la consommation d’alcool, de l’exercice
physique, de l’indice de masse corporelle, de la prise de médicament contre l’hypertension,
de la pression artérielle moyenne, de la mesure de la concentration du glucose, du cholestérol
total, des triglycérides, du HDL-cholestérol, du nombre de leucocytes, de l’aspartate amino-
transférase, de l’alanine aminotransférase, de la gamma glutamyl transférase et de l’acide
urique.
Conclusion.— Ces découvertes indiquent qu’un rythme cardiaque plus élevé au repos est006 and May 2007. Subjects meeting any of the follow-
ng criteria were excluded (n = 87): any missing covariate
nformation and ankle brachial index less than 0.9; a his-
ory of arrhythmia or thyroid disease; a history of coronary
eart disease or stroke. After exclusions, 641 participants
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366 men, 275 women) were included in the ﬁnal analysis.
his study was approved by the Institutional Review Board
f Yonsei University College of Medicine and informed con-
ent was obtained from each participant. The examinations
ere performed by medical staff according to standard pro-
edures. Participants were asked about lifestyle behaviour,
ncluding cigarette smoking, alcohol consumption and phys-
cal activity (more or less than two times per week), as well
s whether they were currently undergoing treatments for
ny disease. If so, they were asked for the date of diagnosis
nd a list of current medications. Trained staff reviewed the
ompleted questionnaires and entered the responses into a
atabase. Participants were classiﬁed as non-smokers, ex-
mokers or current smokers. They were also classiﬁed in
erms of alcohol intake as non-drinkers or current drinkers.
ody mass index was calculated as weight divided by height
quared (kg/m2).
After a 12-hour overnight fast, blood samples were
aken from an antecubital vein. WBC counts were quan-
iﬁed by an automated blood cell counter (ADVIA 120,
ayer, NY, USA). Fasting plasma glucose, total cholesterol,
riglycerides, high-density lipoprotein (HDL) cholesterol,
spartate aminotransferase, alanine aminotransferase, -
lutamyltransferase and uric acid were measured using a
itachi 7600-110 Chemistry Autoanalyzer (Hitachi, Tokyo,
apan). Diabetes was deﬁned as a self-reported history of
he disorder or a fasting plasma glucose level greater or
qual to 7.0mmol/L. Hypertension was deﬁned as a self-
eported history of the disorder, systolic blood pressure
reater or equal to 140mmHg or diastolic blood pressure
reater or equal to 90mmHg.
eﬁnition of metabolic syndrome
he modiﬁed National Cholesterol Education Program Adult
reatment Panel III (NCEP-ATP III) was used for the def-
nition of metabolic syndrome [16]. Metabolic syndrome
as deﬁned by the presence of three or more of the fol-
owing risk factors: waist circumference greater or equal
o 90 cm for men and greater or equal to 80 cm for
omen [17]; high triglyceride concentration (≥ 150mg/dL);
ow HDL-cholesterol concentration (< 40mg/dL for men
nd < 50mg/dL for women); elevated systolic blood pres-
ure (≥ 130mmHg) or elevated diastolic blood pressure
≥ 85mmHg); high fasting plasma glucose concentration
≥ 100mg/dL), based on the revised American Diabetes
ssociation criteria [18]. Subjects who reported taking anti-
ypertensive or antidiabetic medications were considered to
ave elevated blood pressure or high fasting plasma glucose.
rachial-ankle pulse wave velocity
easurement
n automatic waveform analyzer (model BP-203RPE; Colin
o., Komaki, Japan) was used to measure PWV. This
nstrument simultaneously records venous blood pressure,
honocardiogram, electrocardiogram and arterial blood
ressure at both brachial arteries and ankles. Participants
ere examined in the supine position after 10minutes of
ed rest. Electrocardiogram electrodes were placed on both
rists and a microphone for the phonogram was placed
n the left edge of the sternum. Pneumonic cuffs were
c
s
e
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rapped around both upper arms and ankles and connected
o a plethysmographic sensor to determine the volume pulse
aveform. Waveforms for the upper arm (brachial artery)
nd ankle (tibial artery) were stored for 10-s sample times
ith automatic gain analysis and quality adjustment. Oscil-
ometric pressure sensors were attached to the cuffs to
easure blood pressure in the four extremities. The baP-
Vs were recorded using a semiconductor pressure sensor
1200Hz sample acquisition frequency) and calculated using
he following equation:
La − Lb)/Tba
La and Lb were deﬁned as the distance from the aor-
ic valve to the elbow and to the ankle, respectively. The
istance from the suprasternal notch to the elbow (La)
nd from the suprasternal notch to the ankle (Lb) were
xpressed by:
a = 0.2195 × height of participant (cm) − 2.0734 and
Lb = 0.8129 × height of participant (cm) + 12.328
The time interval between the arm and ankle distance
Tba) was deﬁned as the pulse transit time between the
rachial and tibial arterial pressure waveforms. La and Lb
ere estimated automatically based on the participants’
eights.
tatistical analysis
R quartiles were categorized as follows: Q1≤ 56,
2 = 57—62, Q3 = 63—68, and Q4≥ 69 beats/min. Demo-
raphic and biochemical characteristics of the study
opulation according to HR quartiles were compared using
ne-way analysis of variance for continuous variables and
he chi-squared test for categorical variables. Age-adjusted
aPWV means and standard errors were calculated using
nalysis of covariance according to HR quartiles. Indi-
iduals were divided into two groups based on baPWV:
he high group (> 75th percentile) and the low group
≤ 75th percentile). Therefore, a high baPWV was deﬁned
s greater than 1450 cm/s. The odds ratios for high baP-
Vs were calculated using a multivariable logistic regression
nalysis after adjusting for confounding variables across HR
uartiles. All analyses were conducted using SAS statistical
oftware, version 9.1 (SAS Institute Inc, Cary, NC, USA). All
tatistical tests were two-sided, and statistical signiﬁcance
as determined at a P-value less than 0.05.
esults
he study population characteristics according to HR quar-
iles are shown in Table 1. Systolic blood pressure, diastolic
lood pressure, fasting plasma glucose, uric acid and WBC
ounts were highest in Q4. The prevalence of metabolic
yndrome increased in accordance with HR quartiles.
Fig. 1 shows the age-adjusted means and standard
rrors of baPWV (cm/s) according to HR quartiles. The
ge-adjusted means increased gradually according to HR
H
eart
rate
and
arterialstiffness
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Table 1 Clinical and chemical characteristics of the study population according to heart rate quartile.
Heart rate quartiles P-value
Q1 (≤ 56 beats/min)a
(n = 131)
Q2 (57—62 beats/min)a
(n = 174)
Q3 (63—68 beats/min)a
(n = 177)
Q4 (≥ 69 beats/min)a
(n = 159)
Age (years) 50.7 (11.6) 48.3 (11.7) 46.9 (11.6) 47.0 (11.7) 0.023
Women 32.8 47.1 46.9 42.1 0.048
Body mass index
(kg/m2)
23.9 (2.5) 23.5 (3.0) 23.9 (2.8) 23.9 (3.1) 0.597
Current smoker 22.9 17.8 20.3 22.0 0.127
Alcohol ingestionb 71.7 69.5 75.1 66.6 0.373
Regular exercisec 51.1 58.6 64.9 56.6 0.102
Systolic blood pressure
(mmHg)
119.6 (15.4) 117.4 (16.0) 119.2 (14.8) 123.2 (14.3) 0.005
Diastolic blood pressure
(mmHg)
73.0 (11.5) 70.9 (12.2) 73.4 (11.2) 75.9 (12.2) 0.002
Fasting plasma glucose
(mmol/L)
5.3 (0.8) 5.2 (0.7) 5.4 (1.2) 5.6 (1.5) 0.008
Total cholesterol
(mmol/L)
5.1 (0.9) 4.9 (0.9) 5.0 (0.9) 5.0 (0.9) 0.383
HDL-cholesterol
(mmol/L)
1.2 (0.3) 1.3 (0.3) 1.2 (0.3) 1.2 (0.3) 0.514
Triglyceride (mmol/L) 1.2 (0.7) 1.2 (1.0) 1.3 (1.3) 1.4 (1.0) 0.137
WBC count (× 109
cells/L)
5.3 (1.2) 5.3 (1.3) 5.6 (1.5) 5.8 (1.3) 0.001
Hypertensiond 23.5 20.1 20.9 28.9 0.222
Diabetese 4.6 3.5 3.4 8.2 0.143
Metabolic syndrome 22.1 23.0 30.5 32.7 0.084
Data are expressed as mean (standard deviation) or percentage.
HDL-cholesterol: high-density lipoprotein cholesterol; WBC: white blood cell.
a Resting heart rate.
b Alcohol drinking≥ 20 g/day.
c Regular exercise≥ once/week.
d Hypertension was deﬁned as systolic blood pressure≥ 140mmHg, diastolic blood pressure≥ 90mmHg, or a history of the disorder.
e Diabetes was deﬁned as fasting plasma glucose concentration≥ 7.0mmol/L, or a history of the disorder.
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Figure 1. Age-adjusted means of brachial-ankle pulse wave
velocity according to heart rate quartile. Bars represent standard
errors. * P < 0.01. ** P < 0.05. PWV: pulse wave velocity.
Table 2 Correlation between brachial-ankle pulse wave
velocity and other indicators of cardiovascular risk.
Variables ra P-valueb
Age 0.624 < 0.001
Heart rate 0.159 < 0.001
White blood cell count 0.200 < 0.001
Framingham risk score 0.470 < 0.001
Metabolic syndrome 0.373 < 0.001
a Correlation coefﬁcient.
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alter arterial elastic properties, leading to structural stiff-b P-value by Pearson’s correlation analysis.
uartiles: Q1 = 1281 (17.1), Q2 = 1285 (14.8), Q3 = 1354
14.7), and Q4 = 1416 (15.5) cm/s.
Table 2 shows the correlation between baPWV and other
ndicators for cardiovascular risk. BaPWV was signiﬁcantly
orrelated with age, HR, WBC count, Framingham risk score
nd metabolic syndrome.
Table 3 shows the risk for high baPWV according to
R quartiles. In multiple logistic regression model 1, the
dds ratios (95% conﬁdence intervals [CIs]) for high baP-
Vs across the HR quartiles were 1.00, 1.10 (0.57—2.14),
.65 (1.39—5.04) and 4.74 (2.47—9.09), respectively,
fter adjusting for age and sex. We also assessed the
ssociation between HR and the risk for high baPWV
fter additional adjustment for cigarette smoking, alco-
ol intake, regular exercise, body mass index, hypertension
n
t
n
t
Table 3 Odds ratios and 95% conﬁdence intervals for a high b
quartiles.
Heart rate quartiles
Q1 Q2 Q3
Model 1a 1.00 1.11 (0.57—2.14) 2.65 (
Model 2b 1.00 1.06 (0.54—2.05) 2.60 (
Model 3c 1.00 1.28 (0.57—2.86) 2.63 (
a Adjusted for age and sex.
b Adjusted for age, sex, smoking status, alcohol intake, regular exerci
c Adjusted for age, sex, smoking status, alcohol intake, regular exerc
cation, hyperlipidaemia medication, mean arterial blood pressure, fas
lipoprotein cholesterol, white blood cell count, aspartate aminotransf
acid.B.-J. Park et al.
edication, diabetes medication, hyperlipidaemia medica-
ion, mean blood pressure, fasting plasma glucose, total
holesterol, triglycerides, HDL-cholesterol, WBC count,
spartate aminotransferase, alanine aminotransferase, -
lutamyltransferase and uric acid. The associations were
imilar after using models 2 and 3 (Table 3). The multivari-
ble adjusted odds ratios (95% CI) for the highest versus
he lowest quartile of HR were 4.58 (2.38—8.83) and 3.66
1.66—8.05), respectively, in model 2 and model 3.
iscussion
n this cross-sectional study, we found a positive associa-
ion between resting HR and baPWV, independent of classic
ardiovascular risk factors. This association remained after
djusting for other potential risk and confounding factors.
high baPWV was deﬁned as greater than 1450 cm/s in our
tudy. This cut-off value can be used as a surrogate marker
or increased arterial stiffness because a baPWV greater
han 1400 cm/s has been shown to be a useful predictor
f cardiovascular disease [19]. Moreover, our study showed
hat baPWV was signiﬁcantly correlated with Framingham
isk score.
Arterial stiffness is caused by structural and functional
hanges within the arterial walls, resulting in an increased
WV. Some mechanisms could explain the signiﬁcant rela-
ionship between resting HR and arterial stiffness. Firstly,
ecause resting HR can reﬂect an autonomic balance,
higher HR may indicate a higher ratio of sympa-
hetic/parasympathetic activity [20], which can lead to
ncreased vascular tone and resistance [21]. Increased sym-
athetic tone is positively correlated with a higher rate
f oxygen consumption and increased production of proin-
ammatory cytokines, such as interleukin-6 and tumour
ecrosis factor-alpha [22,23]. These cytokines play a key
ole in regulating vessel wall tone by affecting the release
f nitric oxide and endothelin-1 in the subendothelial space
24,25]. This cascade may cause endothelial dysfunction andess. Mayer et al. reported that beta-adrenergic blocker
reatment attenuated resting HR and interleukin-6 simulta-
eously in heart failure patients under higher sympathetic
one status [26]. Additionally, Borovikova et al. showed
rachial-ankle pulse wave velocity, according to heart rate
P for trend
Q4
1.39—5.04) 4.74 (2.47—9.09) < 0.001
1.36—4.97) 4.58 (2.38—8.83) < 0.001
1.20—5.79) 3.66 (1.66—8.05) < 0.001
se and body mass index.
ise, body mass index, hypertension medication, diabetes medi-
ting plasma glucose, total cholesterol, triglycerides, high-density
erase, alanine aminotransferase, -glutamyltransferase and uric
R[
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[
[22] Das UN. Beneﬁcial effect(s) of n-3 fatty acids in cardiovascular
diseases: but, why and how? Prostaglandins Leukot Essent FattyHeart rate and arterial stiffness
that vagal nerve stimulation reduced biomarkers of systemic
inﬂammation [27]. Secondly, a higher HR may also reﬂect
an increased metabolic rate, leading to increased oxidative
stress and chronic low-grade inﬂammation. WBC count is a
usual marker of systemic inﬂammation, and it was high-
est in the fourth HR quartile of the present study. WBC
count is a useful predictor of coronary artery disease, stroke,
peripheral artery disease, carotid atherosclerosis, hyperten-
sion and diabetes [21,28,29]. The signiﬁcant associations
between resting HR and WBC count in the present study
also support the concept that resting HR may be involved
in oxidative stress and systemic inﬂammation. Moreover, we
documented that an elevated WBC count was associated
with arterial stiffness in a previous study [11]. Therefore,
resting HR and arterial stiffness may be linked by a chronic,
low-grade inﬂammation in the vessel walls. In an animal
study, induced tachycardia has been proposed to elevate
the level of cardiac nicotinamide adenine dinucleotide and
mitogen-activated protein kinase, indicators of oxidative
stress to heart [7].
Our study showed the similar patterns of association
between resting HR and baPWV after adjusting for the
presence of drugs that could modify both HR and PWV,
such as blood pressure-lowering drugs, antidiabetic drugs,
and lipid-lowering drugs. Until now, no human studies
have been performed to show the beneﬁt of HR-slowing
measures in participants without heart disease. However,
recent epidemiological studies in patients with heart disease
have reported that HR slowing improves prognosis, whereas
increased HR has detrimental effects on survival [30,31].
Therefore, resting HR may have its own effects on car-
diovascular properties that are independent of HR-altering
manoeuvres.
Our study had several limitations. Firstly, it was a cross-
sectional design, which suggests that caution should be
used in causal interpretations. Interestingly, acute faster
HR induced by a pacemaker may increase PWV in humans
[32]. However, this result does not represent a structural
change but rather a functional one within individuals. Our
study focused on chronic intrinsic properties of HR in indi-
viduals rather than the functional effects resulting from
temporal HR change. Secondly, only one resting HR measure-
ment was included in the analysis. However, it is important
to note that although ambulatory HR varies from hour to
hour according to activity, resting HR is stable and repre-
sents basal metabolic rate and autonomic activity for a long
period of time.
Conclusion
Our ﬁndings demonstrate that a higher resting HR is inde-
pendently associated with arterial stiffness. Accordingly,
early detection of increased resting HR is important in the
assessment of potential cardiovascular risk and could be an
initiative for HR slowing and the prevention of cardiovascu-
lar disease.
Conﬂict of interest statementNone. [251
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